vimarsana.com

Page 5 - க்ளேண்மர்க் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY for Q1 FY 2021-22

Mumbai (Maharashtra) [India], August 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2021.

Glenmark Pharma reports revenue growth of 26%

Glenmark Life Sciences Q1 profit rises to Rs 100 9 cr; revenue up 32 2%

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.